Literature DB >> 9476822

Associations between body morphology and bone mineral density in premenopausal women.

P Orozco1, J M Nolla.   

Abstract

UNLABELLED: To investigate whether body morphology, obesity and its long time evolution were associated with lumbar and femoral bone mineral density (BMD) in premenopausal women of the same age.
DESIGN: Cross-sectional study.
SUBJECTS: 72 healthy premenopausal women born in 1950 (42 years) with a regular physical activity. MEASUREMENTS: BMD measured by dual-X-ray absorptiometry (DEXA) at lumbar spine and proximal femur; body weight, body mass index (BMI), BMI at 20 years (BMI-20), increase in BMI since age of 20 (BMI->20), body circumferences (breast, waist, hip) and their ratios (WHR, BHR, WBR), smoking and alcohol intake.
RESULTS: Lumbar spine BMD did not correlate with any anthropometric measurement. Femoral BMDs correlated positively with weight, BMI, BMI-20, breast, waist, WHR and BHR. The BMI-20 explained the 5% and the current BMI the 13% of variance of total femur BMD. After adjustment for weight or BMI, breast circumference and BHR remained significantly correlated with all femoral BMDs sites except neck. Weight was the best predictor for neck BMD (R2 = 0.08; p < 0.02), and BHR for Ward's triangle (R2 = 0.12; p < 0.01) and trochanter (R2 = 0.10; p < 0.001). Alcohol intake, cigarette smoking, and age of menarche were not related to BMDs.
CONCLUSION: In premenopausal women of the same age, lumbar spine BMD was not associated with any anthropometric measurement. Greater BHR and its long time of evolution may be determinants of greater femoral BMD (trabecular), whereas body weight may be determinant of femoral neck BMD (cortical). Further studies are needed to determine whether large breast to hip ratio may be considered as a protective factor for femoral osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9476822     DOI: 10.1023/a:1007309722100

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  31 in total

1.  Estrogen status and heredity are major determinants of premenopausal bone mass.

Authors:  R Armamento-Villareal; D T Villareal; L V Avioli; R Civitelli
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

2.  Cigarette smoking, steroid hormones, and bone mineral density in young women.

Authors:  M Daniel; A D Martin; D T Drinkwater
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

3.  The influence of body size, smoking, and diet on bone density in pre- and postmenopausal women.

Authors:  S Franceschi; D Schinella; E Bidoli; L Dal Maso; C La Vecchia; F Parazzini; R Zecchin
Journal:  Epidemiology       Date:  1996-07       Impact factor: 4.822

4.  Bone mineral density, sex steroids, and mineral metabolism in premenopausal smokers.

Authors:  N Ortego-Centeno; M Muñoz-Torres; J Hernandez-Quero; A Jurado-Duce; J de la Higuera Torres-Puchol
Journal:  Calcif Tissue Int       Date:  1994-12       Impact factor: 4.333

5.  Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women.

Authors:  D J Evans; R G Hoffmann; R K Kalkhoff; A H Kissebah
Journal:  J Clin Endocrinol Metab       Date:  1983-08       Impact factor: 5.958

6.  Cigarette smoking and bone mineral density in the elderly.

Authors:  P Egger; S Duggleby; R Hobbs; C Fall; C Cooper
Journal:  J Epidemiol Community Health       Date:  1996-02       Impact factor: 3.710

7.  Age and anthropometric determinants of radial bone mass in premenopausal Caucasian women: a cross-sectional study.

Authors:  L Halioua; J J Anderson
Journal:  Osteoporos Int       Date:  1990-10       Impact factor: 4.507

8.  Excess androgenicity only partially explains the relationship between obesity and bone density in premenopausal women.

Authors:  S M Haffner; R L Bauer
Journal:  Int J Obes Relat Metab Disord       Date:  1992-11

9.  Relation between body size and bone mineral density in elderly men and women.

Authors:  S L Edelstein; E Barrett-Connor
Journal:  Am J Epidemiol       Date:  1993-08-01       Impact factor: 4.897

10.  Exercise, smoking, and calcium intake during adolescence and early adulthood as determinants of peak bone mass. Cardiovascular Risk in Young Finns Study Group.

Authors:  M J Välimäki; M Kärkkäinen; C Lamberg-Allardt; K Laitinen; E Alhava; J Heikkinen; O Impivaara; P Mäkelä; J Palmgren; R Seppänen
Journal:  BMJ       Date:  1994-07-23
View more
  6 in total

Review 1.  Effects of weight loss on bone status after bariatric surgery: association between adipokines and bone markers.

Authors:  Hélène Wucher; Cécile Ciangura; Christine Poitou; Sébastien Czernichow
Journal:  Obes Surg       Date:  2007-12-11       Impact factor: 4.129

2.  Bone mass decreases in morbidly obese women after long limb-biliopancreatic diversion and marked weight loss without secondary hyperparathyroidism. A physiological adaptation to weight loss?

Authors:  Dimitrios D A Tsiftsis; Panagiotis Mylonas; Nancy Mead; Fotis Kalfarentzos; Theodore K Alexandrides
Journal:  Obes Surg       Date:  2009-08-29       Impact factor: 4.129

3.  Salivary testosterone is associated with higher lumbar bone mass in premenopausal healthy women with normal levels of serum testosterone.

Authors:  P Orozco; M A Navarro; J M Nolla
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

4.  Beta3-adrenergic receptor gene, body mass index, bone mineral density and fracture risk in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES).

Authors:  Claire Y Wang; Nguyen D Nguyen; Nigel A Morrison; John A Eisman; Jacqueline R Center; Tuan V Nguyen
Journal:  BMC Med Genet       Date:  2006-07-05       Impact factor: 2.103

5.  Disease Systems Analysis of Bone Mineral Density and Bone Turnover Markers in Response to Alendronate, Placebo, and Washout in Postmenopausal Women.

Authors:  J Berkhout; J A Stone; K M Verhamme; M Danhof; T M Post
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-11-21

6.  Application of a Systems Pharmacology-Based Placebo Population Model to Analyze Long-Term Data of Postmenopausal Osteoporosis.

Authors:  J Berkhout; J A Stone; K M Verhamme; B H Stricker; M C Sturkenboom; M Danhof; T M Post
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-08-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.